Healthcare - Biotechnology - NASDAQ - US
$ 3.16
-15.1 %
$ 8.83 M
Market Cap
-0.8
P/E
INCOME STATEMENT
570 K
REVENUE
-22.9 M
OPERATING INCOME
-20.3 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Vaccinex, Inc.
| Revenue | 570 K |
| Cost Of Revenue | 16.6 M |
| Gross Profit | -16 M |
| Operating Expenses | 23.5 M |
| Operating Income | -22.9 M |
| Other Expenses | -2.63 M |
| Net Income | -20.3 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 0.6 | 100 K | 0.9 | 50 K | 0.5 | 0.7 | 90 K | 0.3 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 16.6 | 0.2 | 0.2 | 2 K | 0.2 | 1.0 | 0.2 | 0.1 |
| Gross Profit | (16.0) | (0.1) | 0.7 | 48 K | 0.3 | (0.3) | 70 K | 0.2 |
| OPERATING INCOME | ||||||||
| Operating Expenses | 23.5 | 20.0 | 23.4 | 28.4 | 32.3 | 27.0 | 21.0 | 20.5 |
| Selling, General and Administrative Expenses | 6.9 | 6.2 | 6.2 | 7.4 | 6.7 | 4.6 | 4.5 | 4.4 |
| Research and Development Expenses | 16.6 | 14.0 | 17.2 | 21.5 | 25.7 | 22.4 | 16.6 | 16.0 |
| Operating Income | (22.9) | (19.9) | (22.5) | (28.3) | (32.0) | (27.3) | (21.1) | (20.3) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 1 K | 2 K | 0.8 | 0.5 | 0 | 0.4 | 1.4 | 3.0 |
| Total Other Income | 2.6 | 91 K | 0.1 | (0.5) | 0.2 | (2.2) | 2.3 | 6.3 |
| Pre-Tax Income | (20.3) | (19.8) | (22.4) | (28.9) | (31.9) | (29.5) | (18.8) | (13.9) |
| NET INCOME | ||||||||
| Tax Provision | 0 | 93 K | 0.9 | 0.5 | 0.2 | (1.8) | 1.3 | 3.0 |
| Net Income | (20.3) | (19.7) | (23.2) | (29.3) | (32.0) | (29.5) | (18.7) | (13.9) |
| EPS | 43.7 | 97.6 | 170 | 328 | 522 | 1.19 K | 690 | 527 |